
Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for ...
Introduction Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors worldwide. Although recent studies have shown a decreasing trend in the incidence of HCC, it is still one of the leading causes of cancer deaths.1 Transarterial …